Keywords
How to Cite
Abstract
Introduction: Fuchs' Endothelial Dystrophy is a degenerative ocular condition that compromises the endothelial layer of the cornea, crucial for maintaining corneal transparency and visual function. Characterized by the progressive degeneration of endothelial cells, the progression of this disease can lead to blurred vision and eye pain due to the accumulation of fluid in the cornea. Early diagnosis is of paramount importance for effective management and preservation of vision, as timely treatment can prevent significant progression of the disease.
Objectives: Analyze and improve approaches for the early diagnosis of Fuch's Endothelial Dystrophy. Methodology: To obtain data, resources from the following repositories were used: Scientific Electronic Library Online (SCIELO), PubMed and Latin American Caribbean Literature in Health Sciences (LILACS). A variety of sources, including scientific articles, monographs and journals, were examined to extract pertinent information on the subject. Results and Discussions: The study indicates that both endothelial cell counting microscopy and optical coherence tomography (OCT) are effective tools for the early diagnosis of Fuchs Endothelial Dystrophy. Endothelial cell counting microscopy revealed a significant decrease in endothelial cell density and the presence of abnormal cells, which is indicative of early stages of the disease. OCT provided detailed images of corneal thickness and allowed visualization of changes in the endothelial layer, facilitating the identification of edema and irregularities in the corneal structure. Conclusion: The study demonstrated that the combination of endothelial cell counting microscopy and optical coherence tomography (OCT) is crucial for the early diagnosis of Fuchs Endothelial Dystrophy. These techniques, by offering a detailed analysis of cell density and structural changes in the cornea, allow for early detection of the disease and the implementation of more effective interventions.
References
BRANDÃO, Bruno Raphael Tadeu Moraes et al. Aspectos Genéticos da Distrofia Endotelial de Fuchs. Brazilian Journal of Implantology and Health Sciences, [S. l.], v. 6, n. 7, p. 3152-3165., 12 maio 2024.
BRANDÃO, Bruno Raphael Tadeu Moraes et al. REVISÃO SISTEMÁTICA DE LITERATURA SOBRE TRANSPLANTE LAMELAR EM TRATAMENTO DE DISTROFIA ENDOTELIAL DE FUCHS. Revista FT, [S. l.], v. 27, n. 21, p. 1-24, 12 maio 2023.
BRITO, Sofia Cruz. Suspeita de Distrofia Endotelial de Fuchs, Readaptação de Lentes de Contacto Hidrófilas Tóricas, Disfunção das Vergências Fusionais. 2020. Relatório de estágio para obtenção do grau de Mestre em Optometria e Ciências da Visão (Mestrado) - Faculdade de Ciências da Saúde, [S. l.], 2020.
BROCKMANN, T. et al. Predictive Factors for Clinical Outcomes after Primary Descemet’s Membrane Endothelial Keratoplasty for Fuchs’ Endothelial Dystrophy. Current Eye Research, v. 44, n. 2, p. 147–153, 1 fev. 2019.
ELEIWA, T. et al. Diagnostic Performance of 3-Dimensional Thickness of the Endothelium-Descemet Complex in Fuchs’ Endothelial Cell Corneal Dystrophy. Ophthalmology, v. 127, n. 7, p. 874–887, jul. 2020.
LIU, X. et al. Genetic mutations and molecular mechanisms of Fuchs endothelial corneal dystrophy. Eye and Vision, v. 8, p. 24, 15 jun. 2021.
MACSAI, M. S.; SHILOACH, M. Use of Topical Rho Kinase Inhibitors in the Treatment of Fuchs Dystrophy After Descemet Stripping Only Cornea, v. 38, n. 5, p. 529–534, maio 2019.
MALHOTRA, D. et al. Human Corneal Expression of SLC4A11, a Gene Mutated in Endothelial Corneal Dystrophies. Scientific Reports, v. 9, n. 1, p. 9681, 4 jul. 2019.
MELLO, Paulo; “Qual a importância que você dá para seus olhos?” Disponível em: https://saude.abril.com.br/coluna/com-a-palavra/qual-a-importancia-que-voce-da-para-seus-olhos/ encontrado em 01 de setembro de 2022, às 18:45 horas.
MINGO-BOTÍN, David MD, PhD, et al. Repeatability and Intersession Reproducibility of Pentacam Corneal Thickness Maps in Fuchs Dystrophy and Endothelial Keratoplasty. The Journal of Cornea and External Disease; v.37, n.8, p 987-992, 2018.
MOLONEY, G, et al. Descemet Stripping Only Supplemented With Topical Ripasudil for Fuchs Endothelial Dystrophy 12-Month Outcomes of the Sydney Eye Hospital Study. Cornea ;v.40, n.3, p.320-32, 2021.
MORSHIRFAR, M, PARKER, L, BIRDSONG, OC, et al. Use of Rhokinase inhibitors in ophthalmology: a review of the literature. Med Hypothesis Discov Innov Ophthalmol 2018; 7:101–11.
PATEL, S. V. et al. Repeatability of Scheimpflug Tomography for Assessing Fuchs Endothelial Corneal Dystrophy. American Journal of Ophthalmology, v. 215, p. 91–103, jul. 2020.
SARNICOLA, C.; FAROOQ, A. V.; COLBY, K. Fuchs Endothelial Corneal Dystrophy: Update on Pathogenesis and Future Directions. Eye & Contact Lens, v. 45, n. 1, p. 1–10, jan. 2019.
SAVIAN, Tiago Rezende et al. TRATAMENTO DA DOENÇA DE FUCHS: REVISÃO DE ENSAIOS CLÍNICOS. International Journal of Health Management, [S. l.], v. 8, n. 1, p. 1-10, 2 maio 2022.
SILVEIRA, Victória d’Azevedo; CONTE, Thaís Saorin; GUS, Patrícia Ioschpe. Genética e doenças da córnea: abordagem diagnóstica. EOftalmo, [S. l.], v. 7, n. 4, p. 171-177, 8 set. 2021.
ZANDER DB, Böhringer D, Fritz M, et al. Hyperosmolar Eye Drops for Diurnal Corneal Edema in Fuchs' Endothelial Dystrophy: A Double-Masked, Randomized Controlled Trial. Ophthalmology; v..128, n.11, p.1527-1533, 2021.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Bruno Raphael Tadeu Moraes Brandão , Fernanda Teixeira Emerick, Cristiane de Carvalho Rios , Fábio José da Rocha , Jones Lopes Silva, Thanner Ferrando, Guillermo Cândido de Lorena , Robson Denis de Almeida Miranda, Genivaldo Pereira De Freitas, Loraine De Abreu Pereira, Tatiana Rocha da Silva de Freitas, Jones kostrzychi da Silva
